VC Fund Investments
Diagnostics startup Erly Sign raises Rs.16-Cr funding from Ashish Kacholia
Nagpur-based diagnostics startup Erly Sign , owned and operated by Curo Biosciences Private Limited has raised INR 16 crore in pre-Series A funding from Ashish Kacholia.Founded in 2019 by Shubhendra Singh Thakur and Dr Deovrat Begde, ErlySign has developed biomarker-based saliva test kits that can detect oral precancerous conditions in just 15 minutes and aims to make early cancer detection painless, affordable, and accessible.The new funds will be used to complete trials, get CDSCO approvals, and launch its oral cancer detection kit.It is also looking into CRISPR miRNA technology to expand its ability to detect multiple cancers from a single sample.
In Jan 2022, Erly Sign had raised about USD 340,000 angel funding from LetsVenture and Indian Angel Network.
Want to receive such news items in your inbox? Click Here to sign up for a trial.
